INSYS THERAPEUTICS, INC.

Lobbying Spend

—

Filings

Firms Hired

Active Period

2015–2019

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2019	—	2	1
2018	—	4	1
2017	—	4	2
2016	—	4	1
2015	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
K&L GATES LLP	—	8
CROSSROADS STRATEGIES, LLC	—	8

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	13
SENATE	10
Justice, Dept of (DOJ)	2
Office of Management & Budget (OMB)	2

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	16

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 6115th Congress

SUPPORT for Patients and Communities Act

2018 · second_quarter · Firm: K&L GATES LLP

Cited source text and reported amounts

Issues related to opioid addiction including H.R. 6. Issues affecting pharmaceutical manufacturers - no specific legislation.

Client expense: — · Firm income: $80,000

Matched citations: H.R. 6

INSYS THERAPEUTICS, INC. — Lobbying Disclosure | Poliscope